1. Atezolizumab linked with immune-related nephritis

   News item 29 September 2018 Pages: 1 - 1

2. Muscle-related complaints with alirocumab and evolocumab

   News item 29 September 2018 Pages: 2 - 2

3. Regulatory updates following recall of valsartan medicines

   News item 29 September 2018 Pages: 3 - 3

4. Acute respiratory illness with statins and flu vaccine

   Clinical study 29 September 2018 Pages: 4 - 4

5. Adverse effects of aspirin in healthy elderly

   Clinical study 29 September 2018 Pages: 5 - 5

6. Childhood leukaemia following hormonal contraception exposure

   Clinical study 29 September 2018 Pages: 6 - 6

7. Idarucizumab reverses haemorrhagic effects of dabigatran

   Clinical study 29 September 2018 Pages: 7 - 7

8. Immune checkpoint inhibitors: fatal toxic effects

   Clinical study 29 September 2018 Pages: 8 - 8

9. Methotrexate: neurotoxicity in paediatric ALL

   Clinical study 29 September 2018 Pages: 9 - 9

10. News from 34th ICPE

    News item 29 September 2018 Pages: 10 - 11

11. SpA-associated ethesitis/osteitis with vedolizumab

    Clinical study 29 September 2018 Pages: 11 - 11

12. Acetazolamide/topiramate

    Case report 29 September 2018 Pages: 12 - 12

13. Aciclovir

    Case report 29 September 2018 Pages: 13 - 13

14. Adalimumab

    Case report 29 September 2018 Pages: 14 - 14

15. Adalimumab

    Case report 29 September 2018 Pages: 15 - 15

16. Adalimumab

    Case report 29 September 2018 Pages: 16 - 16

17. Afatinib/poziotinib

    Case report 29 September 2018 Pages: 17 - 17

18. Alemtuzumab

    Case report 29 September 2018 Pages: 18 - 18

19. Alteplase

    Case report 29 September 2018 Pages: 19 - 19

20. Alteplase

    Case report 29 September 2018 Pages: 20 - 20

21. Amiodarone

    Case report 29 September 2018 Pages: 21 - 21

22. Amiodarone

    Case report 29 September 2018 Pages: 22 - 22

23. Amiodarone

    Case report 29 September 2018 Pages: 23 - 23

24. Amiodarone

    Case report 29 September 2018 Pages: 24 - 24

25. Amoxicillin

    Case report 29 September 2018 Pages: 25 - 25

26. Amoxicillin/clavulanic acid

    Case report 29 September 2018 Pages: 26 - 26

27. Amphotericin-B-liposomal/fluconazole/itraconazole

    Case report 29 September 2018 Pages: 27 - 27

28. Antibacterials

    Case report 29 September 2018 Pages: 28 - 28

29. Antineoplastics

    Case report 29 September 2018 Pages: 29 - 29

30. Antineoplastics

    Case report 29 September 2018 Pages: 30 - 30

31. Antineoplastics

    Case report 29 September 2018 Pages: 31 - 31

32. Antineoplastics

    Case report 29 September 2018 Pages: 32 - 32

33. Antineoplastics

    Case report 29 September 2018 Pages: 33 - 33

34. Antineoplastics

    Case report 29 September 2018 Pages: 34 - 34

35. Antipsoriatics

    Case report 29 September 2018 Pages: 35 - 35

36. Antiretrovirals

    Case report 29 September 2018 Pages: 36 - 36

37. Antirheumatics/hydroxychloroquine/thalidomide

    Case report 29 September 2018 Pages: 37 - 37

38. Antituberculars

    Case report 29 September 2018 Pages: 38 - 38

39. Antituberculars/moxifloxacin

    Case report 29 September 2018 Pages: 39 - 39

40. Antivirals

    Case report 29 September 2018 Pages: 40 - 40

41. Apixaban/aspirin/clopidogrel

    Case report 29 September 2018 Pages: 41 - 41

42. Apixaban/phenprocoumon

    Case report 29 September 2018 Pages: 42 - 42

43. Apixaban/phenprocoumon/rivaroxaban

    Case report 29 September 2018 Pages: 43 - 43

44. Apomorphine/levodopa

    Case report 29 September 2018 Pages: 44 - 44

45. Ascorbic acid

    Case report 29 September 2018 Pages: 45 - 45

46. Ascorbic acid

    Case report 29 September 2018 Pages: 46 - 46

47. Aspirin

    Case report 29 September 2018 Pages: 47 - 47

48. Aspirin

    Case report 29 September 2018 Pages: 48 - 48

49. Aspirin/clopidogrel/dasatinib

    Case report 29 September 2018 Pages: 49 - 49

50. Aspirin/morphine/vinegar interaction

    Case report 29 September 2018 Pages: 50 - 50